↓ Skip to main content

Dove Medical Press

Repurposing Anti-Cancer Drugs for COVID-19 Treatment

Overview of attention for article published in Drug Design, Development and Therapy, November 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

blogs
1 blog
twitter
4 X users

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
124 Mendeley
Title
Repurposing Anti-Cancer Drugs for COVID-19 Treatment
Published in
Drug Design, Development and Therapy, November 2020
DOI 10.2147/dddt.s282252
Pubmed ID
Authors

Nicholas Borcherding, Yogesh Jethava, Praveen Vikas

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 124 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 16 13%
Researcher 14 11%
Student > Master 11 9%
Other 8 6%
Student > Ph. D. Student 7 6%
Other 18 15%
Unknown 50 40%
Readers by discipline Count As %
Medicine and Dentistry 22 18%
Pharmacology, Toxicology and Pharmaceutical Science 13 10%
Nursing and Health Professions 9 7%
Biochemistry, Genetics and Molecular Biology 6 5%
Agricultural and Biological Sciences 3 2%
Other 19 15%
Unknown 52 42%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 June 2022.
All research outputs
#3,485,675
of 26,017,215 outputs
Outputs from Drug Design, Development and Therapy
#206
of 2,296 outputs
Outputs of similar age
#86,213
of 444,455 outputs
Outputs of similar age from Drug Design, Development and Therapy
#1
of 38 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,296 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.3. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,455 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.